| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_715361dca5a5d31cd9c1a11ae5d8c47f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2021-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f1b6cb8be6b77c11a690e59e4a6959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a97454df9161a7c94a57088f2b73c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2856de01ceae4a2d46750809acf0f5a2 |
| publicationDate |
2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022113139-A1 |
| titleOfInvention |
Formulation for oral administration of active compounds with low bioavailability and corresponding production method |
| abstract |
A formation for oral administration of active compounds with generally low bioavailability comprises one or more lipophobic, apolar or moderately apolar active compounds and one or more lipid excipients. |
| priorityDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |